Total Payments
$44,485
2024 Payments
$28.25
Companies
6
Transactions
70
Medicare Patients
281
Medicare Billing
$21,045
Payment Breakdown by Category
Other$30,100 (67.7%)
Consulting$7,250 (16.3%)
Travel$5,244 (11.8%)
Food & Beverage$1,891 (4.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $30,100 | 9 | 67.7% |
| Consulting Fee | $7,250 | 2 | 16.3% |
| Travel and Lodging | $5,244 | 28 | 11.8% |
| Food and Beverage | $1,891 | 31 | 4.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Pharmacyclics LLC, An AbbVie Company | $43,816 | 62 | $0 (2019) |
| Janssen Biotech, Inc. | $365.23 | 3 | $0 (2023) |
| ADC Therapeutics America, Inc. | $242.70 | 2 | $0 (2023) |
| BeiGene USA, Inc. | $28.25 | 1 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $17.77 | 1 | $0 (2018) |
| MorphoSys, US Inc. | $14.87 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28.25 | 1 | BeiGene USA, Inc. ($28.25) |
| 2023 | $400.89 | 4 | ADC Therapeutics America, Inc. ($242.70) |
| 2019 | $8,346 | 8 | Pharmacyclics LLC, An AbbVie Company ($8,233) |
| 2018 | $35,374 | 54 | Pharmacyclics LLC, An AbbVie Company ($35,356) |
| 2017 | $335.37 | 3 | Pharmacyclics LLC, An AbbVie Company ($226.90) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/09/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $28.25 | General |
| Category: Oncology | ||||||
| 12/10/2023 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $143.32 | General |
| Category: Oncology | ||||||
| 12/10/2023 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $142.71 | General |
| 11/14/2023 | MorphoSys, US Inc. | MONJUVI (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Oncology | ||||||
| 08/10/2023 | ADC Therapeutics America, Inc. | — | Food and Beverage | In-kind items and services | $99.99 | General |
| 12/06/2019 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $113.44 | General |
| Category: Oncology | ||||||
| 01/31/2019 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,800.00 | General |
| Category: Oncology | ||||||
| 01/31/2019 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $118.29 | General |
| Category: Oncology | ||||||
| 01/31/2019 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Travel and Lodging | In-kind items and services | $116.75 | General |
| Category: Oncology | ||||||
| 01/24/2019 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,800.00 | General |
| Category: Oncology | ||||||
| 01/24/2019 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Travel and Lodging | In-kind items and services | $225.87 | General |
| Category: Oncology | ||||||
| 01/24/2019 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Travel and Lodging | In-kind items and services | $158.34 | General |
| Category: Oncology | ||||||
| 01/24/2019 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Oncology | ||||||
| 11/08/2018 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,800.00 | General |
| Category: Oncology | ||||||
| 11/08/2018 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Travel and Lodging | In-kind items and services | $137.89 | General |
| Category: Oncology | ||||||
| 11/08/2018 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $90.81 | General |
| Category: Oncology | ||||||
| 11/01/2018 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,800.00 | General |
| Category: Oncology | ||||||
| 11/01/2018 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Travel and Lodging | In-kind items and services | $102.02 | General |
| Category: Oncology | ||||||
| 11/01/2018 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $92.95 | General |
| Category: Oncology | ||||||
| 10/31/2018 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $75.48 | General |
| Category: Oncology | ||||||
| 10/31/2018 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Travel and Lodging | In-kind items and services | $38.00 | General |
| Category: Oncology | ||||||
| 10/31/2018 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Oncology | ||||||
| 10/31/2018 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $10.49 | General |
| Category: Oncology | ||||||
| 10/31/2018 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Travel and Lodging | In-kind items and services | $9.05 | General |
| Category: Oncology | ||||||
| 10/29/2018 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Consulting Fee | Cash or cash equivalent | $5,250.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 60 | 87 | $14,679 | $4,328 |
| 2022 | 3 | 73 | 106 | $17,478 | $5,200 |
| 2021 | 3 | 82 | 125 | $24,925 | $7,563 |
| 2020 | 2 | 66 | 98 | $18,162 | $3,955 |
Total Patients
281
Total Services
416
Medicare Billing
$21,045
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 41 | 62 | $9,054 | $2,485 | 27.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 19 | 25 | $5,625 | $1,843 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 43 | 66 | $10,098 | $2,898 | 28.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 18 | 28 | $6,300 | $2,050 | 32.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 12 | 12 | $1,080 | $252.33 | 23.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 53 | 70 | $10,710 | $2,822 | 26.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 12 | 23 | $7,015 | $2,500 | 35.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 17 | 32 | $7,200 | $2,241 | 31.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 29 | 44 | $9,900 | $2,447 | 24.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 37 | 54 | $8,262 | $1,508 | 18.3% |
About Dr. Roger Fleischman, MD
Dr. Roger Fleischman, MD is a Internal Medicine healthcare provider based in Lexington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902815814.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roger Fleischman, MD has received a total of $44,485 in payments from pharmaceutical and medical device companies, with $28.25 received in 2024. These payments were reported across 70 transactions from 6 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($30,100).
As a Medicare-enrolled provider, Fleischman has provided services to 281 Medicare beneficiaries, totaling 416 services with total Medicare billing of $21,045. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology, Medical Oncology
- Location Lexington, KY
- Active Since 08/07/2006
- Last Updated 09/17/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1902815814
Products in Payments
- Imbruvica (Drug) $43,816
- DARZALEX (Biological) $365.23
- BRUKINSA (Drug) $28.25
- IMBRUVICA (Drug) $17.77
- MONJUVI (Drug) $14.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lexington
Dr. Firas Badin, M.d, M.D
Internal Medicine — Payments: $1.9M
Internal Medicine $1.9M
Dennis Doherty, Md, MD
Internal Medicine — Payments: $686,622
Internal Medicine $686,622
Dr. Robert Sawyer, M.d, M.D
Internal Medicine — Payments: $232,104
Internal Medicine $232,104
David Mannino, Md, MD
Internal Medicine — Payments: $140,029
Internal Medicine $140,029
Dr. Anastasia Jandes, Md, MD
Internal Medicine — Payments: $90,742
Internal Medicine $90,742
Gloria Vigliani, M.d, M.D
Internal Medicine — Payments: $89,452
Internal Medicine $89,452